Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes

INTRODUCTION: Ki-67 labeling index assessed by immunohistochemical assays has been shown useful in assessing the risk of recurrence for estrogen receptor (ER)-positive HER2-negative breast cancers (BC) and distinguishing Luminal A-like from Luminal B-like tumors. We aimed to assess the performance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Viale, Giuseppe, Hanlon Newell, Amy E., Walker, Espen, Harlow, Greg, Bai, Isaac, Russo, Leila, Dell’Orto, Patrizia, Maisonneuve, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797656/
https://www.ncbi.nlm.nih.gov/pubmed/31422497
http://dx.doi.org/10.1007/s10549-019-05402-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797656/
https://www.ncbi.nlm.nih.gov/pubmed/31422497
http://dx.doi.org/10.1007/s10549-019-05402-w

Ejemplares similares